Back to Journals » OncoTargets and Therapy » Volume 12

A significant response to a combination of trastuzumab and vinorelbine in HER2-negative metastatic breast cancer with HER2 V777L mutation

Total article views   HTML views PDF downloads Totals
6,470 Dovepress* 5,281+ 867 6,148
PubMed Central* 1,189 200 1,389
Totals 6,470 1,067 7,537
*Since 17 April 2019
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar